Catalyze, Transform and Invest in the future of life sciences.
-
20+
Successful Investments
-
10
Exits
-
3
FDA Approvals
About CTI
Catalyze. Transform. Invest.
We lead companies with great ideas to flourish, evolve and reach their value potential
CTI Life Sciences Fund is a knowledge-driven boutique venture capital firm. We leverage our deep, complementary, and collective intelligence to deliver strong results on investments in Life Sciences.
Our mission is to catalyze emerging science, transform business objectives, and invest in scalable companies within Canada, the United States and Europe. In doing so, we aim to deliver impactful innovations and strong returns to a large sphere of stakeholders across biotechnology and healthcare.
We are the Catalysts for Transformative Investments.
OUR TEAM
GREAT COMPANY BUILDS GREAT COMPANIES.
Our diverse and knowledgeable team leverages their combined business experience, deep scientific intelligence, and track record in drug development to make rationalized investment decisions. Our all-inclusive approach ensures that we make measured investments with confidence for the benefit of our shareholders and patients.
-
KEN PASTOR
Managing Partner
Founding Partner of the CTI Life Sciences Fund franchise.
25+ years of investment banking, portfolio manager for major Canadian financial institution and a boutique investment firm.
Extensive expertise in negotiation, valuation of private and public companies, deal structuring and risk management.
-
LAURENCE RULLEAU
Managing Partner
Partner at CTI LSF since 2014 and Life sciences Investor for over 25 years.
Deep experience in mergers and acquisitions as well as in/out-asset-licensing.
Active member of the life science ecosystem as a board director of Admare Bioinnovation and member of Women Innovating Together in Healthcare (WITH), Women in Bio (WIB) and Reseau-Elle.
-
YOUSSEF BENNANI
Managing Partner
Pharmaceutical Executive, 30 years R&D experience.
Leadership, Management and Governance corporate experience.
Multi-therapeutic, disease-area expertise.
-
SHERMAINE TILLEY
Managing Partner
Over 20 years of biotech investing and board experience, including as Partner in each of CTI LSF I – III.
Integrated scientific and financial structuring expertise associated with demonstrated returns.
Passionate about helping to shape innovative young businesses to achieve timely value inflection.